Search

Search Constraints

You searched for: Author/Creator Kvien, Tore K

Search Results

1. 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target. Issue 1 (29th March 2021)

2. 169 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through three years: long-term data from the FUTURE 1 and FUTURE 2 studies. (25th April 2018)

3. 176 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through three years: long-term results of two randomised double-blind placebo-controlled phase III studies. (25th April 2018)

4. 184 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis: two year results from the FUTURE 2 study. (25th April 2018)

5. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Issue 9 (10th August 2010)

6. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Issue 1 (26th September 2014)

7. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Issue 6 (13th January 2017)

8. 2016 update of the EULAR recommendations for the management of early arthritis. Issue 6 (15th December 2016)

10. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Issue 8 (3rd September 2009)